RAFAEL HOLDINGS, INC. Disposal Group, Including Discontinued Operation, Operating Income (Loss)
RAFAEL HOLDINGS, INC. (RFL) reported Disposal Group, Including Discontinued Operation, Operating Income (Loss) of -$219.00 thousand for the 12-month period ending 2023-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for the quarter ending 2023-07-31 was -$65.00K.
- RAFAEL HOLDINGS, INC. disposal group, including discontinued operation, operating income (loss) for fiscal 2023 was -$219.00K.
| Period end | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 3 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 9 month | Disposal Group, Including Discontinued Operation, Operating Income (Loss) 12 month |
|---|---|---|---|
| 2023-07-31 | -$65.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | -$219.00K 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | -$154.00K 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |